儿童期晚发型胰岛自身免疫:青年糖尿病自身免疫研究(DAISY)
前瞻性队列纳入2547名高危HLA基因型或有一级亲属1型糖尿病的儿童,随访至21年。持续存在胰岛自身抗体者分为早发型(<8岁,n=143)与晚发型(≥8岁,n=64)。晚发型更常见于西班牙裔或非裔美国人,进展至糖尿病显著更慢(p<0.001),约半数晚发型者进展为多种自身抗体并在青春期或成年早期发展为糖尿病。
要点
- 晚发型胰岛自身免疫更常见于西班牙裔或非裔美国人(p=0.004)。
- 晚发型更易表现为单一自身抗体(p=0.01)并逆转为抗体阴性(p=0.01)。
- 晚发型胰岛自身免疫者进展至糖尿病显著更慢(p<0.001)。
核心结论
- 晚发型胰岛自身免疫更常见于非裔美国人和西班牙裔个体。
- 约半数晚发型胰岛自身免疫者进展为多种胰岛自身抗体并在青春期或成年早期发展为糖尿病。
- 进一步研究晚发型自身免疫的环境决定因素可能有助于理解和预防青少年及成人起病1型糖尿病。
研究设计与样本
- 前瞻性队列研究,纳入2547名来自一般人群的高危HLA基因型儿童及有一级亲属患1型糖尿病的儿童,随访长达21年。
- 持续存在一种或以上胰岛自身抗体者分为早发型(<8岁,n=143,中位3.3年)和晚发型(≥8岁,n=64,中位11.1年),分别随访中位7.4年和4.7年。
- 采用Kaplan-Meier分析和logrank检验评估进展至糖尿病,采用参数加速失效时间模型分析进展相关因素。
主要发现
- 晚发型胰岛自身免疫儿童更可能为西班牙裔或非裔美国人而非非西班牙裔白人(p=0.004),更不可能是1型糖尿病患者的兄弟姐妹(p=0.04)。
- 两组间HLA-DR3/4基因型频率及与1型糖尿病相关的非HLA基因变异频率无差异。
- 年龄和HLA-DR3/4是进展至出现额外自身抗体和1型糖尿病速率的重要预测因素。
- 晚发型更可能表现为单一胰岛自身抗体(p=0.01)并逆转为抗体阴性状态(p=0.01)。
- 晚发型胰岛自身免疫儿童进展至糖尿病显著更慢(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We sought to assess the frequency, determinants and prognosis for future diabetes in individuals with islet autoimmunity and whether these factors differ depending on the age of onset of islet autoimmunity. METHODS: A prospective cohort (n = 2547) of children from the general population who had a high-risk HLA genotype and children who had a first-degree relative with type 1 diabetes were followed for up to 21 years. Those with the persistent presence of one or more islet autoantibodies were categorised as early-onset (<8 years of age, n = 143, median 3.3 years) or late-onset (≥8 years of age, n = 64, median 11.1 years), and were followed for a median of 7.4 and 4.7 years, respectively. Progression to diabetes was evaluated by Kaplan-Meier analysis with logrank test. Factors associated with progression to diabetes were analysed using the parametric accelerated failure time model. RESULTS: Children with late-onset islet autoimmunity were more likely to be Hispanic or African-American than non-Hispanic white (p = 0.004), and less likely to be siblings of individuals with type 1 diabetes (p = 0.04). The frequencies of the HLA-DR3/4 genotype and non-HLA gene variants associated with type 1 diabetes did not differ between the two groups. However, age and HLA-DR3/4 were important predictors of rate of progression to both the presence of additional autoantibodies and type 1 diabetes. Late-onset islet autoimmunity was more likely to present with a single islet autoantibody (p = 0.01) and revert to an antibody-negative state (p = 0.01). Progression to diabetes was significantly slower in children with late-onset islet autoimmunity (p < 0.001). CONCLUSIONS/INTERPRETATION: A late onset of islet autoimmunity is more common in African-American and Hispanic individuals. About half of those with late-onset islet autoimmunity progress to show multiple islet autoantibodies and develop diabetes in adolescence or early adulthood. Further investigation of environmental determinants of late-onset autoimmunity may lead to an understanding of and ability to prevent adolescent and adult-onset type 1 diabetes.
引用
- Frohnert BI, Ide L, Dong F, et al. Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia. 2017. PMID: 28314946. doi:10.1007/s00125-017-4256-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。